*HCL TECHNOLOGIES 1Q NET 18.2B RUPEES, EX ADJUSTMENT
*HCL TECHNOLOGIES 1Q NET 17.3B RUPEES
*HCL TECHNOLOGIES 1Q REVENUE 101B RUPEES; EST. 100.8B
*HCL TECHNOLOGIES 1Q EBITDA 22.1B RUPEES VS 21.9B
*HCL TECH SAYS 1Q ADJUSTMENT ON ONE TIME PROVISION FOR PROJECT
*HCL TECHNOLOGIES 1Q EBITDA MARGIN 21.9% VS 25.1% YR AGO
*HCL TECHNOLOGIES 1Q GROSS MARGIN 34.4% VS 36.8% YR AGO
*HCL TECH APPROVES ARRANGEMENT WITH HCL COMNET
*HCL TECHNOLOGIES TO PAY 5 RUPEES/SHR INTERIM DIVIDEND

Call of 13/10/15 TUESDAY


@ 15:21


Buy Dr Reddy ltp 4243 SL 4180 
trgt ..4284/4316


ALL TRGT HIT

Major Results to be announced in the forthcoming sessions:

19th October: HCL Tech, SKS Micro, Hind Zinc, Petronet, Gruh Fin, Gati

20th October: ACC, Hero Motors, DHFL, Federal Bank, Bajaj Fin, Biocon, Jyothy Labs, Can Fin Homes, Kajaria Ceramics, Everest Inds, Mphasis

21st October: HDFC BANK, Wipro, Bajaj Auto, India Bulls Housing Fin, IRB, Jsw Steel, Idea, Cairn, IB Real Est, Bajaj Holding, M&M Fin, Blue Dart, Intellect, Tata Coffee

22nd October: Cadila
                                                                      23rd October: Asian Paints, Bharti Infratel, Rallis

24th October: L&T Fin

26th October: Bharti Airtel, HDFC

27th October: Axis Bank, Lupin, TVS Motors, Dish TV, Vedanta, GIC Housing

28th October: Ambuja Cement, Dabur, Pidilite, Amaraja Battery, Exide, JSW Energy

29th October: Dr Reddy, Bharat Forge, Crompton Greaves, Colpal, MRF, GPPL

30th October: ICICI Bank, Kotak Bank, LT, Titan, Apollo Tyres, KTK Bank, Century Textiles, BEL

31st October: IDFC

3rd Nov: Tech M, Hexaware, ABB, Berger Paint, PVR, Prism Cem

4th Nov: Ashok Leyland, Repco Home

5th Nov: Tata Steel, Jubilant Foods

6th Nov: M&M, Godrej Ind, Union Bank

7th Nov: Britannia, VaTech Wabag

9th Nov: BPCL, Tata Power...

FWD: ET NOW BROKERAGE

CLSA ON RIL
@darshanetnow
Maintain Buy, Target `1230
A 9% beat on 2Q PAT as GRM rises to seven-year high
Catalysts: Jio, ecommerce ventures, commissioning of petcoke projects
Raise FY16/17 EPS by 6/3% building in strong Q2, higher GRMs
Stock may already be building in a $15bn negative value for telecom

BOFA ML ON RIL
@darshanetnow
Maintain Neutral, Target `1068
Refining surprises positively while petrochemicals was in line
Strong downstream outlook with E&P likely to remain a drag
Downstream capacity on track but ramp ups likely slower
Seven year high GRM of US$10.6/bbl was much better than expected

GOLDMAN SACHS ON RIL
@darshanetnow
Raise target to `1136 from `1091, Maintain Buy
Raise FY16 EPS forecast by 19%; FY18 by 4% on strong Q2
Beat driven by highest premium to Singapore Complex GRM in 6 years
GRMs were driven by increased gasoline yield, crude discount
Expect RIL to benefit from the refining upcycle starting 2016

UBS ON RIL
@darshanetnow
Maintain Buy, Target `1090
Superior downstream operations with good progress on 4G launch
Catalyst: Downstream capex-led growth and rapid 4G subscriber additions
Stock attractive on EV/EBITDA, P/BV valuations

MORGAN STANLEY ON LIC HOUSING
@darshanetnow
Downgrade to Equal Weight from Overweight, Target `490
Expect theincremental spread to moderateas bank baseratecuts accelerate
NIM expansion appears largely done; loan growth is moderating
Earnings should be good but weview valuation as full

MORGAN STANLEY ON RIL
@darshanetnow
Maintain Overweight, Target `1200
Telecom commercial operations are likely from April 2016
Downstream projects' impact should bereflected fully from Jan-17

KOTAK ON RIL
@darshanetnow
Maintain Add, Target `1080
Raise EPS estimates by 3-8%
Strong refining, steady petchem and dismal E&P performance
Better performance versus muted expectations in telecom will be crucial driver

*RELIANCE INDUSTRIES 2Q NET 65.6B RUPEES; EST. 58.4B
*RELIANCE INDUSTRIES 2Q SALES 608.2B RUPEES; EST. 613.9B
*RELIANCE 2Q RAW MATERIAL COSTS 399.8B RUPEES VS 788.5B
*RELIANCE 2Q TOTAL COSTS 533.6B RUPEES VS 904.8B
*RELIANCE 2Q OTHER INCOME 16.2B RUPEES VS 21.4B
*RIL TELLS EMPLOYEES ONGC HAS NO CLAIMS IN KG BASIN GAS ROW: PTI
*RELIANCE INDUSTRIES 2Q NET 65.6B RUPEES; EST. 58.4B

Call of 13/10/15 TUESDAY


@ 15:21


Buy Dr Reddy ltp 4243 SL 4180 
trgt ..4284/4316


FIRST TRGT HIT

HCL Tech results on 19 th

Support around 820 zone 
Can buy near support 
Above 843 can go 857..874

Call of 15/10/15



@  09:36


Buy HDFC Bank 1094 Sl  1080 Trgt 1101



Trgt hit

Call of 15/10/15


@ 14:21



Buy Ashok Leyland around 94 SL 93 trgt 96/98

Frst trgt achvd 

Made high of 96.90

Call of 16/10/15


@ 14:08



Buy Nifty fut abv 8180 SL 8140 trgt 8214


HIT TRGT

STOCK UPDATE

ADANI POWER: Has won a contract for supply of 50 MW power to Indian Railways
for three years at a landed price of 3.69 rupees per unit. (Cogencis)

* AMTEK AUTO: Has hired Morgan Stanley to find buyers for a minority stake in
its overseas units. (ET)

* AXIS BANK: The Enforcement Directorate has unearthed a foreign exchange
scam related to the bank. (CNBC TV18)

* COLGATE PALMOLIVE INDIA: Domestic institutional investors' stake in the
company fell 255 bps on quarter to 5.93% as on Sep 30, while foreign
institutional investors' stake rose marginally to 17.64% from 17.29% earlier.
(Cogencis)

* CYIENT: Has posted a net profit of 985.2 mln rupees for Jul-Sep, up 9.25%
year-on-year and net sales of 7.05 bln rupees, up 4.9% on year. (Cogencis)

* DCB BANK: The Enforcement Directorate has unearthed a foreign exchange scam
related to the bank. (Various)

* DHANLAXMI BANK: The Enforcement Directorate has unearthed a foreign exchange
scam related to the bank. (Various)

* DLF: Securities and Exchange Board of India has requested the Supreme Court to
restrict DLF's fund-raising plan and stop the company and its affiliates from
dealing in securities in any manner till the outcome of a pending appeal in
the court relating to non-disclosure of information during its 2007 IPO. (ET)

* FINANCIAL TECHNOLOGIES INDIA: National Spot Exchange has opposed Ministry of
Corporate Affairs' proposal to merge it with the company terming it "illegal
and malafide". (IE)

* GAIL INDIA: Has signed a pact with Jharkhand government for construction of
the company's Jagdishpur-Haldia gas pipeline. (Cogencis)
    Petroleum and Natural Gas Regulatory Board has ordered encashing part of the
company's performance bank guarantee after the state-owned firm failed to
achieve financial closure of the Surat-Paradip gas pipeline project even after
three years. (ET)
    The company and NTPC will invest 5 bln rupees each into a separate company
formed to take care of the liquefied natural gas business of the former's
Ratnagiri Gas and Power Pvt Ltd, while a consortium of banks will invest
another 10 bln rupees. (BL)

* GUJARAT STATE PETRONET: Foreign institutional investors' stake in the
company rose by 248 basis points quarter-on-quarter to 13.76% Sep-end, while
domestic institutional investors' stake rose by 187 bps to 31.59%. (Cogencis)

* HARRISONS MALAYALAM: Workers at the company's plantation ended their 17-day
strike after it reached an "amicable" settlement with the trade unions.
(Cogencis)

* HIMATSINGKA SEIDE: Has posted a net profit of 415.8 mln rupees for Jul-Sep,
up 76.79% on year and net sales of 5.3 bln rupees, up 4.7% on year. (Cogencis)

* HINDUSTAN PETROLEUM CORP: Public Enterprises Selection Board has recommended
M.K. Surana's name for the next Chairman and Managing Director of the company.
(Cogencis)

* HOUSING DEVELOPMENT & INFRASTRUCTURE: Foreign institutional investors' stake
in the company declined by 388 basis points quarter-on-quarter to 44.50% as of
Sep-end, while domestic institutional investors' stake rose by 44 bps to 0.6%.
(Cogencis)

* ICICI BANK: The Enforcement Directorate has unearthed a foreign exchange scam
related to the bank. (various)

* INDUSIND BANK: Foreign institutional investors' stake in the company rose by
420 basis points quarter-on-quarter to 42.8% Sep-end, while domestic
institutional investors' stake rose by 161 bps to 11.02%. (Cogencis)
    The Enforcement Directorate has unearthed a foreign exchange scam related
to the bank. (various)

* ING VYSYA BANK: The Enforcement Directorate has unearthed a foreign exchange
scam related to the bank. (various)

* JET AIRWAYS INDIA: Has announced 19 new domestic flights as a part of its
winter schedule. (Cogencis)

* L&T INFRASTRUCTURE FINANCE: Plans to raise up to 1 bln rupees, including
greenshoe option of 500 mln rupees, through issuance of non-convertible
debentures on a private placement basis. (Cogencis)

* KOTAK MAHINDRA BANK: The Enforcement Directorate has unearthed a foreign
exchange scam related to the bank. (various)

* MINDTREE: Has posted a net profit of 1.6 bln rupees for Jul-Sep, up 15.14%
on year and income from operations of 7.05 bln rupees, up 31.6% on year.
(Cogencis)
    The board of Mindtree have approved the merger of two of its US-based
subsidiaries, Discoverture Solutions LLC and Relational Solutions Inc, with
itself. (Cogencis)

* NESTLE INDIA: National Consumer Disputes Redressal Commission has ordered
testing 13 samples of Maggi noodles in Mysore to determine if the samples
contained any lead and monosodium glutamate. (Cogencis)

* ORIENTAL BANK: The Enforcement Directorate has unearthed a foreign exchange
scam related to the bank. (CNBC TV18)

* PARSVNATH DEVELOPERS: Has launched a two-, and three-bedroom residential
project "Parsvnath Aakanksha" in Jodhpur. (Cogencis)

* POWER FINANCE CORP: Life Insurance Corp of India's stake in company rose by
295 basis points sequentially to 10.82% in the quarter ended September, while
domestic Institutional Investors' stake in the company rose 421 bps to
13.90%. (Cogencis)

* RAYMOND: Is investing $100 mln to set up a plant of capacity 2 mln units
per annum in Ethiopia to make and export woollen-blended, cotton-blended
jackets. (FE)

* SKF INDIA: Foreign institutional investors' stake in the company increased
by 430 basis points on quarter to 12.34% as on Sep 30, while domestic
institutional investors' stake fell 401 basis points to 20.02%. (Cogencis)

* SPICEJET: Will start operating late-night flights on the domestic
circuit--between Delhi and Bengaluru and Delhi and Nanded, from Nov 2.
(Cogencis)

* SUBROS: Has received an order worth 150 mln rupees from Indian Railways to
supply cab mounted heating, ventilating and air conditioning units. (Cogencis)

* TATA CHEMICALS: Has launched a range of spices under the Tata Sampann
brand, priced between 35 and 80 rupees for a 20-gm pack. (Cogencis)

* TATA MOTORS: The company's group global wholesale sales, including those of
UK-based arm Jaguar Land Rover Automotive Plc, rose 21% year-on-year to
97,102 units in September on the back of higher passenger vehicles sales.
(Cogencis)

* TORRENT POWER: Central Electricity Regulatory Commission has approved a
tariff of 6.29 rupees a unit for the company's 1,147.5 MW SUGEN power plant
in Gujarat for 2014-19 (Apr-Mar). (Cogencis)

* UNITECH: Plans to raise 13-14 bln rupees through sale of land and stakes
in existing projects. (Mint)

* V-GUARD INDUSTRIES: Has posted a net profit of 230.63 mln rupees for
Jul-Sep, up 20.33% on year and net sales of 4.3 bln rupees, up 0.9% on year.
(Cogencis)

* YES BANK: The Enforcement Directorate has unearthed a foreign exchange
scam related to the bank. (various) End

RESULTS TODAY:

RIL, Edelweiss, Agro Tech Foods, NIIT Tech, Swaraj Engines, Tata Metaliks.

CALL OF 15/10/2015 

@12:10 


BUY LUPIN LTP 2090 SL 2080 TRGT 2110

TRGT HIT

Call of 13/10/15 TUESDAY


@  14:30


Buy Nifty Oct Fut ltp 8118 SL ( 8093)
trgt 8140 /8160



FIRST TRGT HIT
Exit 50% Trail to cost for no loss in rest 50%


TODAY ALL TRGT HIT

Breaking news :

Raghuram Rajan said if fed hike then we have to also prepare for rate hike as rate cut not pass on by banks to people..

Call of 28/09/15 MONDAY


@ 10:29



Buy Auro pharma ltp 763 SL 720 trgt 800/812


ALL TRGT HIT

EARNINGS: Bloomberg Est.

 * LIC Housing Finance 2Q 4.11b (21)
 * MindTree 2Q 1.53b (15)
 * Sintex Industries 2Q 1.17b (4)
 * Cyient 2Q 880m (10)
 * D.B. Corp 2Q 679m (7)
 * Karur Vysya Bank 2Q 1.32b (7)
 * Lakshmi Vilas Bank 2Q 437m (3)
 * V-Guard Industries 2Q 226m (7)
 * CCL Products 2Q 330m (4)
 * Mastek
http://www.cnbc.com/2015/10/14/reuters-america-stronger-sugar-shines-in-commodities-as-speculators-stay-positive.html
Virtusa a NASDAQ listed company is in final stage of talk with Polaris for aquisition for $350mn 20% premium to current market Cap of Polaris. ....ET  +ve  for intellect  design
just In: Torrent Pharma, Alembic Pharma Receive US FDA Nod For Memantine Hydrochloride.              

 JUST NOW  : Dr Reddy's gets USFDA tentative nod for Lamotrigine. Exclusive: Temasek exits Bharti Infratel
(Singapore government's investment unit Temasek has exited its nearly eight year old investment in Bharti Airtel’s telecommunication tower arm Bharti Infratel Ltd by selling its remaining holding in the company )
* Recently, KKR also exited the tower arm of Bharti Airtel.
http://www.vccircle.com/news/telecom/2015/10/14/exclusive-temasek-exits-bharti-infratel
  DIC India Q3
Net Profit At `7.4 Cr Vs `2.1 Cr (YoY)
Total Income Up 4.2% At `192.4 Cr Vs `184.6 Cr (YoY)
ET NOW: Brokerage Radar:
CLSA ON HUL : Maintains Sell; cuts target to ₹740 from ₹810
CLSA ON HUL : Cutting EPS estimates by 6% over FY16-18
CLSA ON HUL : Impact of input price deflation led to a miss in revenues, margins

GOLDMAN SACHS ON HUL : Maintains Sell; target cut to  ₹716 from ₹740
GOLDMAN SACHS ON HUL : Correlation between volume and pricing  has dropped sharply
GOLDMAN SACHS ON HUL : Lowest revenue growth in 10 years driven by pricing deflation

CREDIT SUISSE ON HUL : Maintains Outperform; target cut to ₹920 from ₹990
CREDIT SUISSE ON HUL : Earnings miss on higher ad spending,  Volume growth key positive
CREDIT SUISSE ON HUL : Lowers EPS estimates by 4-6%
CREDIT SUISSE ON HUL : Cut estimates as co will invest most of  its gross margin gains in ad spend

BofA ML ON HUL : Maintain Neutral; target cut to  ₹891 from ₹950
BofA ML ON HUL : Operating numbers miss expectations; see limited upside to share price
BofA ML ON HUL : Q2 saw healthy volume growth but higher A&P and taxes hurt

CLSA ON ZEE ENT : Maintains Buy, raises target to ₹488 from ₹484
CLSA ON ZEE ENT : Ad growth acceleration to 35% which is a 4-year high
CLSA ON ZEE ENT : Domestic subscription revenues to accelerate as Phase 3 nears
CLSA ON ZEE ENT : Believe stock can double over the next 3 years
CLSA ON ZEE ENT : Domestic subscription revenues to accelerate as Phase III nears

BofA ML ON ZEE ENT : Maintains Buy, raises target to ₹460 from ₹450
BofA ML ON ZEE ENT : Strong core numbers due to 35% ad growth
BofA ML ON ZEE ENT : Key positives: Ad growth; Margin uptake; lower losses

CLSA ON TTK PRESTIGE : Maintains Buy; target raised to ₹5,140 from ₹4,550
CLSA ON TTK PRESTIGE : Sales growth accelerates; margins increase and profits beat
CLSA ON TTK PRESTIGE : Management expects double-digit sales growth in H2FY16

CS ON TTK PRESTIGE : Maintains Neutral; target raised to ₹3,850 from ₹3,510
CS ON TTK PRESTIGE : Margin expansion after a long time, should accelerate in 2H
CS ON TTK PRESTIGE : Return of double-digit sales growth driven by non-south, new launches
CS ON TTK PRESTIGE : Managing e-commerce much better now, channel conflict is largely behind

MS ON ZEE : Maintains Equal Weight, raises target to ₹370 from ₹332
MS ON ZEE : Raising earnings estimates by 2% on lower sport losses, ad revenues

MS ON FMCG : Downgrades Godrej Consumer, Asian Paints to Equalweight from Overweight
MS ON FMCG : Downgrades Nestle to Underweight from Equaleeight, tgt cut to ₹5720 from ₹6485
MS ON FMCG : Raises Dabur target to ₹320 from ₹290, Marico to ₹440 from ₹425
MS ON FMCG : Cuts HUL target to ₹880 from ₹905, Asian Paints to ₹875 from ₹905
MS ON FMCG : Cuts Tata Global target to ₹118 from ₹146, Colgate to ₹840 from ₹850

UBS ON THERMAX : Maintains Sell; target cut to ₹770 from ₹960
UBS ON THERMAX : Delayed industrial recovery should reset expectations
UBS ON THERMAX : Utility equipment JV to take time to turn around
UBS ON THERMAX : Order inflow trajectory suggests order book depletion will continue

NOMURA ON COLGATE : Maintains Reduce; target cut to ₹811 from ₹763
NOMURA ON COLGATE : Does not deserve to trade at a premium over HUL
NOMURA ON COLGATE : Cuts FY16/FY17 earnings by 4.9%/9.3% on low volume expectation
NOMURA ON COLGATE : Remains a single category player with industry slowing.

Nifty is not able to cross 8142 level from last three days 
And is consolidating. 
If breaks 8090... 8070...8040 zone we can see selling pressure again 
Buying momentum above 8142

Call of 06/10/15 TUESDAY

@ 09:42


Buy Tata chemical  ltp 404 SL 396 trgt 408/416

                                                                                 
All   TRGT HIT

Call of 13/10/15 TUESDAY


@  14:30


Buy Nifty Oct Fut ltp 8118 
SL ( 8093)
trgt 8140 /8160



FIRST TRGT HIT

VIEW ON COMMODITIES:

Gold : Gold can be a good buying accumulation around 26520. if trades below 26320, we can see it falling to 26240 and lower levels  but if holds the support of 26520, it can show 26920 levels..

Natural Gas : NG is showing positive sign for the month. If gives closing above 165.20, it can rise to 175 levels in coming days. If faces resistance around 165, we can see it falling again to 159-160 levels.

Copper :  Copper is showing some reversal pattern. Above 353, we can see 368 levels and if maintains below 344, then 329 is coming on its way.  

Crude : Crude is showing trend reversal patterns. Above 3300, it can go higher levels. And if breaks 2900, we can again see selling pressure.

Nickel : Nickel is not able cross 700 of last month. If maintains below 674, we can see it again falling to 640 levels , if maintains above 700 uptrend can resume. 

Silver : Silver is showing positive trend. If maintains 36500, we can see higher levels. But if maintains below 36400, then 35200 is on its way..

Today's Results

Hindunilever
Zeel
Tcs

HUL  ET NOW Q2 Preview
Net Sales 8013cr vs 7639cr, up 7.5% YoY
Net Profit 1256cr vs 957cr, up 31% YoY

Cipla gets Form 483 for US Invagen plant.
Cipla's new U.S. plant received Form 483 just ahead of Deal

Last month India's Cipla announced it had struck a $550 million deal to buy its first U.S. property, InvaGen Pharmaceuticals, getting a 350,000-square-foot manufacturing facility and portfolio of drugs. What it left out of the announcement is that its first U.S. manufacturing operation came with some FDA concerns. The company received a Form 483 this spring for that plant, which the FDA did not post until two weeks after the deal was disclosed.

China Sep CPI Inflation print coming in lower at 1.6% YoY vs est for 1.8% and 2% in Aug is likely to raise the market expectations for further monetary easing by its Central Bank.

Arrests in @Barodabank scam: ED arrests 4 people for illegal remittance of #Forex worth Rs 6000 cr to Hong Kong.
Arrests in @Barodabank scam: Kamal Kalra, official in #Forex dept of leading bank arrested.
Arrests in @Barodabank scam: CBI arrests BoB AGM and Branch head SK Garg & also Forex incharge Jainis Dubey.

CNBC-TV18 Exclusive DG Anti- Dumping: Recommends Anti-Dumping Duty On Cold Rolled Stainless Steel For 5 Years


 CNBC-TV18 Exclusive DG Anti- Dumping: Recommendation Of Anti-Dumping Duty Positive For Jindal Stainless, SAIL

GOLDMAN SACHS ON TCS

Maintain buy, Target `2900
TCS has not met revenue growth expectations for the past few quarters
We see 2QFY16 as the bottom and expect better yoy growth
TCS trades at a 19% premium to peers which is justified by its returns

CLSA ON BHARAT FORGE

Downgrade to Sell from Buy, Target `745 from `1465
Simultaneous growth slowdown in key export segments
Slow pace of recovery in domestic industrials business
Cut 16-18 EPS 7-26% and are now 9-21% below consensus
Long-term positives but cyclical issues overshadowing near term

CLSA ON TCS

Maintain Buy, Target `3200
In-line growth and margins with Digital & IMS firing
Drags from Japan and Diligenta should wash away by 4Q
Expect TCS growth rates to strengthen in FY17
2H to see normal seasonality, order wins underpin FY17 growth

CS ON TCS

Cut target to `3000 from `3100, Maintain Outperform
Revenue slightly below expectations; other metrics in line
Management seems less concerned about 2H compared to Infosys
Cut numbers slightly due to higher tax rate assumptions

UBS ON REAL ESTATE

Upgrade Prestige Estates to Neutral from Sell, Target `230 from `215
Raise DLF target to `210 from `190, Maintain Buy
Raise IBREL target to `74 from `67, Maintain Neutral
Visible recovery with REIT potential to drive re-rating

CITI ON TCS

Downgrade to Sell from Neutral, Target `2430 from `2765
Downgrading stock on slowing growth and high valuations
Expect slowing growth to put pressure on multiples
Lower estimates by ~2% and multiple to 18x

CNX NIFTY (8143)

Nifty is facing resistance around 8200..8240 from last 2 days, we can see today 8074..8100 zone.

Positional trend is up, 
Strong bounce back zone is 8074...8100

Any close and maintain  below 8050 can again show
Again selling pressure..

INFOSYS

CLSA ON INFOSYS

Cut target to `1325 from `1425, Maintain Buy
Soft guidance and CFO change amidst stellar numbers
Infosys has rediscovered clients using price aggression
Next tough step is defining sources of longterm competitive advantage

CS ON INFOSYS

Rasise target to `1175 from `1150, Maintain Neutral
Strong all-round performance but FY16 guidance maintained
Close to industry leading growth in FY17 would be a tough ask
Growth at the top of the range for peers needed for next phase

BOFA ML ON STEEL

JSW Steel and Sail are the top picks in the sector
Tata Steel likely to benefit from the narrowing pension deficit at TSE
Companies have raised flat steel prices post imposition of safeguard duty
Reduction in producer’s inventory on cards as imports have started trending down
Market concerns of increased CRC imports could be misplaced 
Steep correction in iron ore bodes well for 3Q/4Q earnings 
Decline in imports is much more critical than the price rise

BOFA ML ON INFOSYS

Maintain Buy, Target `1325
Debate on guidance overshadows a strong Q2
Revenue growth was once again broad-based
Stable attrition, in-line margins reflect steady execution

UBS ON INFOSYS

Maintain Sell, Target `810
Q2 FY16 likely to be peak for revenue, share price
Q2 positives - broad-based growth, top-client performance
Q2 Concerns - slowing volume momentum, muted H2 outlook

GS ON OBEROI REALTY

Maintain Buy, Target `406
Oberoi plans to launch its Borivali project over the next month
Borivali launch to increase pre-sales visibility to 4 years
Project has revenue potential of `6000 cr over FY16 - 22
Project has cash flow potential of `4000 cr over FY 16 - 22

GS ON INFOSYS

Maintain Neutral, Target `1100
Weak 2H outlook but valuations are fair
Looks on track to improve its long-term growth trajectory
Weak 2H outlook keeps the trajectory unpredictable
View is  that revenue growth will not match sector leaders

BARCLAYS ON GUJARAT PIPAVAV PORT

Cut target to `196 from `213, Maintain Equal Weight
Competition from JNPT, Hazira, Dahej and Mundra Ports
Traffic growth to be weak near-term and scalability is a challenge
Cut estimates for FY16 - 18 by 1- 17% on recent shift of traffic

Bank nifty (17590)

Bank nifty has to maintain above 17580 to go up 17800..18000


If maintains below 17580 17540 we can see 17340.. 17200

All levels are closing basis

Positional Technicals 

Cnx nifty (8189)

Nifty has to maintain abv 8240 to go up to 8340..8400 level

Strong support lies around 8140..8180 levels

Below 8140 we can see it falling to 7900

NEWS ON INFOSYS:

Infosys Q2: Infosys Lowers FY16 Dollar-Revenue Guidance:

Infosys Q2: FY16 Revenue Guidance At 10-12% In Constant Currency:

Infosys cuts FY16 Dollar growth outlook to 6.4%-8.4%.

CLSA ON INDUSIND BANK
Maintain Buy, Target `1130

Bank stays among our top picks in the banking sector
Core growth, buyout and capital raisings drive top line growth
Casa franchise is scaling-up; base rate transition manageable
Asset quality stable; RWA/total asset ratio stays high
Expect 28% profit CAGR over FY15-18

CS ON NAVKAR CORPORATION

CFS volumes have grown at 10.5% CAGR over FY13-15
Focus on export and hazardous cargo are key differentiators
Mgmt expects strong growth from Vapi ICD, logistics park
Vapi ICD is expected to start shortly on a road basis
Vapi ICD  would connect via rail from 3Q CY16
Management says rail competitive over short distance also

BOFA ML ON AUROBINDO PHARMA
Maintain Buy, Target `935

gAbilify is attractive opportunity; 17 approvals YTD FY16 
gAbilify will add $75mn sales over the next 12 months
Portfolio mix is evolving; injectable launches to ramp-up

UBS ON MOTHERSON SUMI
Cut target to `340 from `355, Maintain Buy
Expect earnings to double in 3 years even in downside case
Strong growth outlook across businesses and M&A upside
Maruti indicates that there is no policy to restrict a vendor to 70% of a business
Sharp market share losses in India unlikely

Drug firm Aurobindo Pharma has received the final approval from the US health regulator FDA to manufacture and market generic Aripiprazole tablets used for treatment of psychotic conditions in the American market.

"The company has received the final approval from the US Food and Drug Administration (USFDA) to manufacture and market Aripiprazole tablets... and the product is ready for launch," Aurobindo Pharma said in a statement on Friday.

The approval is for the tablets in the strengths of 2mg, 5mg, 10mg, 15mg, 20mg and 30mg, it added. The approved ANDA (Abbreviated New Drug Application) is for the generic version of Otsuka Pharmaceutical's Abilify tablets in the same strengths, Aurobindo Pharma said.

The approved product has an estimated market size of USD 7.3 billion for 12 months ending August, the company said stating IMS estimates.

"Aripiprazole tablets are atypical antipsychotic indicated in the treatment symptoms of psychotic conditions such as schizophrenia and bipolar disorder (manic depression)," Aurobindo said. 

The company now has a total of 215 ANDA approvals (187 final approvals including 10 from Aurolife Pharma LLC and 28 tentative approvals)

News from Financial Portals

      
         
#  Japan Sept PMI survey shows services grow at much slower pace         
         
#  Pragmatic Tsipras postpones Greek revolution, trouble lurks          
         
#  Hundreds of thousands protest in Berlin against EU-U.S. trade deal         
         
#  China-backed trade pact playing catch-up after U.S.-led TPP deal         
         
#  China to intensify crackdown on illegal money transfers to fight corruption         
         
#  Commodity surge lifts world equities; dollar falls         
         
#  India cuts holdings of US govt securities to $116.3 bn         
         
#  GMR, Japan's JGC to develop food processing park in Andhra         
         
#  Cotton corporation asked to purchase Punjab cotton         
         
#  Goyal to inaugurate 2 WCL coal mines by month-end         
         
#  India's states to compete for foreign cash as bond market opens up         
         
#  Bandhan Bank to raise Rs 500 crore from investors by March         
         
#  Indirect tax collection this fiscal shows GDP growth robust'         
         
#  Iran says will announce oil and gas contracts in Nov and Feb         
         
#  FPIs halt selling spree, pour in Rs 2,000 cr in Oct so far         
         
#  Pest blights India's GM cotton crop, fuelling debate over risks          
         
#  ONGC may not get much compensation in gas dispute with Reliance Industries         
         
#  FinMin to look into hiking equity investment proposal: PFRDA         
         
#  WPP eyes 10% revenue rise in India, bets on organic growth         
         
#  India's drug stores plan protest against e-pharmacies          
         
#  Kingfisher Airlines owes over Rs.7,000 crore to 17 lenders         
         
#  Sebi fines 34 cos for not fixing investor complaints

IDFC(Initiaties) 
Indian IT sector- 

Indian IT is expected to deliver sustainable double-digit growth despite the volatile economic recovery. Improved business mix would buoy wallet share gains driven by opportunities in disruptive technologies like Cloud, Digital, ER&D, IIoT, BPO and AI. Companies with the right mix of verticals (BFSI, Retail and Telecom – early adopters of Digital) and service offerings (Consulting, Application Development and BPO) would lead the industry. We expect Indian IT to register a CAGR of 12% over FY14-20E. Our picks in the space are the growth leaders – Infosys, Tech Mahindra, TCS, Mindtree, Persistent and Hexaware. Infosys and Tech Mahindra are at the cusp of an earnings upgrade and rerating cycle, whereas TCS would track earnings growth. Among our mid-cap picks, Mindtree, Persistent and Hexaware would outperform driven by sustained industry leading performances. Moreover, the low-to-high-teen valuations of Indian IT despite prospects of double-digit revenue growth provide cushion from downside.

Double-digit growth momentum to sustain:Indian IT is expected to grow at a double-digit rate (12%+ CAGR over FY14-20) driven by market share gains and sustained recovery in the global economy. We believe growth would be driven by: 1) wallet share gain through accelerated Digital spend in the US (23% CAGR over FY14-20E) and 2) greater penetration into newer European geographies (55% market share of sourcing pie), which are at an early stage of the offshoring cycle.

Disruptive technologies – more opportunities than threats: Indian IT has successfully transitioned from just a cost player to a technology partner by improving the business mix. Though Cloud adoption is shrinking the addressable market for IT Services players, we believe Cloud and other disruptive technologies offer Indian IT capacious growth opportunities over FY14-18E: 1) Cloud – 26% CAGR, 2) Managed Security Services – 16%, 3) Enterprise Digital Transformation – 27%, 4) Global ER&D/PES – 15%, 5) IIoT – 35%, 6) BPO – 13% and 7) AI platform – 17%.

Positive on sector, but volatility to stay: A fragile and volatile economic recovery, smaller deal sizes, and disruption in existing business models would induce volatility in the financial performance of the sector. Nevertheless, the capacious growth opportunities would drive revenue/ earnings CAGR of ~11%/ 15% over FY15-18E for our coverage universe. We initiate coverage on Indian IT Services with an Overweight rating. Our top picks are Infosys, TechM and TCS in large-caps, and Mindtree, Persistent, Hexaware and KPIT in mid-caps.

Infosys results

Infosys Q2FY16(QoQ) ET NOW POLL
* $ Revenues: $ 2345 M vs $ 2256 M 
* Revenues: Rs 15225 cr vs Rs 14354 cr (Up 6.06%)
Infosys Q2FY16(QoQ) ET NOW POLL
* EBIT Margin: 24.50% vs 24.01%
* Net Profit : Rs 3292.7 cr vs Rs 3030 cr(Up 8.7%)

Expected Time 
Infosys results at 8.45 am

Infosys Q2FY16 Pre result estimates:

Dollar revenue expected to rise 3.6 percent quarter-on-quarter to USD 2,337 million and rupee revenue is seen rising 5.9 percent to Rs 15,210 crore in the quarter ended September 2015. Earnings before interest and tax (EBIT) may climb 10.2 percent to Rs 3,798 crore and margin may expand 100 basis points sequentially to 25 percent. PAT expected to be seen at 3244 cr versus 3030 cr on QoQ bases. Infosys to maintain its FY16 guidance of 10-12 percent in constant currency (11.5-13.5 percent in rupee terms) and 7.2-9.2 percent in dollar terms (that was increased in previous quarter from 6.2-8.2 percent). (Positive expectations for Infosys, however expectations somewhat priced in as stock already given positive performance recently)

Call of 09/10/15 FRIDAY


@ 09:38



High risk traders Buy Tata Motors ltp 344 
SL 338 trgt 348/354

ALL TRGT HIT

Cnx Nifty (8129)

We can see gap up opening as sgx is trading higher 
Nifty if maintains above 8220 for an hour go long today we can see strong move upto 8320.. 8340..8380 levels 
If maintains below 8190 we can see 8090..60 coming

Motherson biggest client is VW group
No rate hike in USA
Just in : RBI reduces risk weight and Loan to value ratios for banks. Positive for banks.
Big positive for psu banks who r striving for capital
: For 30 lakh category it has been reduced from 50% to 30% with LTV of less than 80%.

Call of 01/09/15 TUESDAY

@ 8:58

Buy ITC  ltp 326 SL 290 
trgt 344/354 /372

Time frame 1 month


FIRST TRGT HIT

Call of 06/10/15 TUESDAY

@ 09:42


Buy Tata chemical  ltp 404 SL 396 
trgt 408/416
                                                                            FIRST TRGT HIT


TODAY'S HIGH 412.50

Call of 01/10/15 THURSDAY



@  9:50



Buy Wock pharma ltp 1534 SL 1504
trgt 1574

TRGT HIT

Call of  01/10/15 THURSDAY

@ 9:51

Buy Ibulhousing ltp 784 SL 770 
trgt 794/798/804


ALL TRGT HIT

September Auto Sales Tata Motors: Jaguar US Sales -12.9% At 995 Units Vs 1,142 Units (YoY)

September Auto Sales Tata Motors: JLR US Sales +61.3% At 6,850 Units Vs 4,248 Units (YoY)

Alembic Pharma gets USFDA nod for Zolmitriptan.

House views
CS on NMDC
Maintains Underperform
TP cut to Rs. 80 from Rs.85

HSBC on Glenmark Pharma
Maintains Hold
TP raised to Rs.1100 from Rs.1082

HSBC on Dr.Reddy’s
Maintains Hold
TP raised to Rs. 4128 from Rs.4105

HSBC on Lupin
Maintains Buy
TP raised to Rs. 2252 from Rs.2002

HSBC on Torrent Pharma
Maintains Buy
TP raised to Rs.1587 from Rs.1549

HSBC on Apollo Hospitals
Maintains Buy
TP raised to Rs.1542 from Rs.1500

UBS on Cipla
Upgraded to Buy from Neutral
TP raised to Rs. 800 from Rs.795

UBS on IPCA Labs
Maintains Neutral
TP raised to Rs. 815 from Rs.760

GS on Mindtree
Maintains Sell
TP raised to Rs. 1150 from Rs.1080

GS on Wipro
Maintains Sell
TP raised to Rs. 530 from Rs.510

GS on HCL Tech
Downgraded to Neutral from Buy
TP cut to Rs. 900 from Rs.1000

GS on Infosys
Maintains Neutral
TP raised to Rs. 1100 from Rs.1050

GS on TCS
Maintains Buy
TP raised to Rs. 2900 from Rs.2850

GS on Tech Mahindra
Maintains Buy
TP raised to Rs. 625 from Rs.610

SG on Tech Mahindra
Maintains Buy
TP raised to Rs. 675 from Rs.625

SG on TCS
Maintains Hold
TP raised to Rs. 2700 from Rs.2480

SG on Wipro
Maintains Buy
TP raised to Rs. 725 from Rs.660


GS on Bharti Airtel
Maintains Buy
TP cut to Rs. 476 from Rs.480

Jefferies on Maruti Suzuki
Downgraded to Underperform from Buy
TP cut to Rs. 3952 from Rs.4876

Jefferies on Coal India
Maintains Buy
TP cut to Rs. 432 from Rs.468

JPMorgan on ONGC
Maintains Neutral
TP cut to Rs. 270 from Rs.345

JPMorgan on Coal India
Maintains Underweight
TP cut to Rs. 340 from Rs.345

Call of 01/10/15 THURSDAY

@10:04


Intraday call
Sell Nifty ltp 8014 SL 8080 
trgt 7984/7960

All trgt achvd

Call of 30/09/15 WEDNESDAY

@  13:32


Buy Colpal ltp 956 SL 940 
trgt 968 /980


FIRST TRGT HIT

STOCK UPDATE

Today we can see good move in 
Wockpharma 
Glenmark
IGL
Ntpc 
Rcom
Ibul housing

NIFTY UPDATE

Nifty has opened gap up but near resistance 
Be cautious !!
Above CNX 8020 can only show uptrend